Skip to main content
. Author manuscript; available in PMC: 2012 Oct 26.
Published in final edited form as: Neuroreport. 2011 Oct 26;22(15):758–761. doi: 10.1097/WNR.0b013e32834ae2a1

Figure 1.

Figure 1

Quantitative RT-PCR reveals an increase in relative GluR1 transcription in the amygdala from PCPA-treated rats. mRNA levels measured by qRT-PCR of amygdala, hippocampus and cortex samples was normalized to 18S rRNA and the ΔC(t) values were calculated for each sample. PCPA treatment (gray squares, n = 3) reduced ΔC(t) in samples from the amygdala (left), but not hippocampus (middle) or cortex (right). *p < 0.05 (unpaired Student’s t-test) relative to samples from PBS-treated control rats (open circles, n = 3). Data represent mean ± S.E.M.